Vivek Garipalli - Clover Health CoFounder Chairman
| CLOV Stock | USD 3.00 0.17 5.36% |
Chairman
Vivek Garipalli is CoFounder Chairman of Clover Health Investments
| Age | 45 |
| Address | 3401 Mallory Lane, Franklin, TN, United States, 37067 |
| Phone | 201 432 2133 |
| Web | https://www.cloverhealth.com/en/ |
Vivek Garipalli Latest Insider Activity
Tracking and analyzing the buying and selling activities of Vivek Garipalli against Clover Health stock is an integral part of due diligence when investing in Clover Health. Vivek Garipalli insider activity provides valuable insight into whether Clover Health is net buyers or sellers over its current business cycle. Note, Clover Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Clover Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Vivek Garipalli over three months ago Acquisition by Vivek Garipalli of 877567 shares of Clover Health at 1.14 subject to Rule 16b-3 | ||
Vivek Garipalli over a year ago Clover Health exotic insider transaction detected |
Clover Health Management Efficiency
The company has return on total asset (ROA) of (0.0566) % which means that it has lost $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.289) %, meaning that it created substantial loss on money invested by shareholders. Clover Health's management efficiency ratios could be used to measure how well Clover Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.36 in 2024. Return On Capital Employed is likely to climb to -0.64 in 2024. At this time, Clover Health's Net Tangible Assets are fairly stable compared to the past year. Total Assets is likely to climb to about 571.4 M in 2024, whereas Other Current Assets are likely to drop slightly above 36.7 M in 2024.Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| John Chen | BlackBerry | 68 | |
| Andrew Paradise | Skillz Platform | 41 | |
Management Performance
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0566 |
Clover Health Investments Leadership Team
Elected by the shareholders, the Clover Health's board of directors comprises two types of representatives: Clover Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clover. The board's role is to monitor Clover Health's management team and ensure that shareholders' interests are well served. Clover Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clover Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brady JD, Chief Care | ||
| Wendy Richey, Chief Officer | ||
| Derrick Nueman, Head strategy | ||
| Prabhdeep Singh, Chief Officer | ||
| Karen Soares, Senior Counsel | ||
| Joseph Martin, Gen Sec | ||
| Kumar Dharmarajan, Chief Assistant | ||
| Conrad Wai, Chief Officer | ||
| Terrence Ronan, Principal CFO | ||
| Andrew Toy, President, CoFounder | ||
| Vivek Garipalli, CoFounder Chairman | ||
| Rachel Fish, Chief Officer | ||
| Scott Leffler, Chief Officer | ||
| Peter Kuipers, Chief Officer | ||
| Jamie Reynoso, Chief Advantage |
Clover Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Clover Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0566 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 1.23 B | ||||
| Shares Outstanding | 412.08 M | ||||
| Shares Owned By Insiders | 5.33 % | ||||
| Shares Owned By Institutions | 20.15 % | ||||
| Number Of Shares Shorted | 15.28 M | ||||
| Price To Book | 4.57 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clover Stock Analysis
When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.